UGT1A1 and Hyperbilirubinemia: Genetic studies of these patients have identified a dinucleotide repeat polymorphism (TA)5–8 in the TATA box of the UGT1A1 gene promoter that is associated with reduced UGT expression and produces hyperbilirubinemia [30]–[31], [37], [46]–[47].